Orange Book product · Brand (NDA)
XTAMPZA ER
OXYCODONE
At a glance
Apr 26, 2016
Approved
Brand (NDA)
Application
Not listed
TE code
8
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 26, 2016
10 yr 4 mo ago
Today
Patent 7771707 expires
Listed drug product patent expiration.
Oct 09, 2028
in 2 yr 4 mo
Patent 10004729 expires
Listed drug product patent expiration.
Dec 10, 2030
in 4 yr 7 mo
Patent 10668060 expires
Listed drug product patent expiration.
Dec 10, 2030
in 4 yr 7 mo
Patent 9682075 expires
Listed drug product patent expiration.
Dec 10, 2030
in 4 yr 7 mo
Patent 10188644 expires
Listed drug product patent expiration.
Sep 02, 2036
in 10 yr 4 mo
Patent 10646485 expires
Listed drug product patent expiration.
Sep 02, 2036
in 10 yr 4 mo
Patent 9737530 expires
Listed drug product patent expiration.
Sep 02, 2036
in 10 yr 4 mo
Patent 9968598 expires
Listed drug product patent expiration.
Sep 02, 2036
in 10 yr 4 mo
Pharmaceutical detail
Active ingredient
OXYCODONE
Strength
36MG
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
NDA 208090
Product number
005
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (8)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7771707 | Oct 09, 2028 | in 2 yr 4 mo | Product |
| 10004729 | Dec 10, 2030 | in 4 yr 7 mo | ProductU-1556 |
| 10668060 | Dec 10, 2030 | in 4 yr 7 mo | ProductU-1556 |
| 9682075 | Dec 10, 2030 | in 4 yr 7 mo | ProductU-1556 |
| 10188644 | Sep 02, 2036 | in 10 yr 4 mo | ProductU-1556 |
| 10646485 | Sep 02, 2036 | in 10 yr 4 mo | ProductU-1556 |
| 9737530 | Sep 02, 2036 | in 10 yr 4 mo | ProductU-1556 |
| 9968598 | Sep 02, 2036 | in 10 yr 4 mo | ProductU-1556 |
